Department of Nursing Science and Midwifery, Centre For Research and Innovation in Care (CRIC), Nurse and Pharmaceutical Care (NuPhaC), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Faculty of Medicine and Health Sciences, Collaborative Antwerp Psychiatric Research Institute, University Department of Psychiatry, University of Antwerp, 2610 Antwerp, Belgium.
Int J Environ Res Public Health. 2022 Apr 15;19(8):4835. doi: 10.3390/ijerph19084835.
AIM(S): The aim of the study was to explore perspectives of hospitalised patients with schizophrenia or a bipolar disorder and their healthcare providers on medication self-management.
In a qualitative descriptive design, semi-structured interviews were used. Forty-nine interviews were completed (nurses = 18; psychiatrists = 3; hospital pharmacists = 2; patients = 26). Data analysis was iterative using an inductive and thematic approach.
From the thematic analysis of the interviews, three main themes emerged: monitoring and shared decision-making, relationship based on trust, and patient satisfaction and rehabilitation; as well as three sub-themes: available tools, patient readiness, and safety. Regular monitoring and follow-ups were considered conditions for medication self-management. All stakeholders considered that the patient, the nursing staff, and the psychiatrist should all be involved in the process of medication self-management. All healthcare providers emphasized the importance of regular re-evaluations of the patient and were worried about medication errors and misuse. Most patients considered medication self-management during hospitalisation to increase their confidence, self-reliance, and satisfaction. Many participants thought it would make a positive contribution to the recovery process.
All stakeholders were positive towards medication self-management under specific conditions. According to the participants, medication self-management offered many benefits, including the implementation of more structure for the patient, an ameliorated preparatory phase towards discharge, and an actual improvement of future adherence. All participants considered medication self-management to contribute to more profound medication knowledge and an overall improvement of their health literacy. Implications and future perspectives: These findings will be used to develop a medication self-management tool in hospitalised patients with schizophrenia or bipolar disorders.
本研究旨在探讨住院精神分裂症或双相情感障碍患者及其医护人员对药物自我管理的看法。
采用定性描述设计，使用半结构式访谈。完成了 49 次访谈（护士=18；精神科医生=3；医院药剂师=2；患者=26）。数据分析采用归纳和主题分析的迭代方法。
通过对访谈的主题分析，出现了三个主要主题：监测和共同决策、基于信任的关系以及患者满意度和康复；以及三个子主题：可用工具、患者准备度和安全性。定期监测和随访被认为是药物自我管理的条件。所有利益相关者都认为患者、护理人员和精神科医生都应该参与药物自我管理过程。所有医护人员都强调定期重新评估患者的重要性，并担心药物错误和滥用。大多数患者认为住院期间的药物自我管理增加了他们的信心、自立和满意度。许多参与者认为这将对康复过程产生积极影响。
所有利益相关者都对特定条件下的药物自我管理持积极态度。根据参与者的说法，药物自我管理有很多好处，包括为患者提供更多的结构、改善出院前的准备阶段，以及实际改善未来的依从性。所有参与者都认为药物自我管理有助于提高药物知识和整体健康素养。
这些发现将用于为住院精神分裂症或双相情感障碍患者开发药物自我管理工具。
